C12N 2506/02
From embryonic cells
Official title: from embryonic cells
C12N2506/02 (From embryonic cells) appears on 1,292 US grants and 2,575 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,292
- Published applications
- 2,575
- Assignees
- 732
- Inventors
- 3,409
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 3 |
| 2002 | 4 | 24 |
| 2003 | 4 | 33 |
| 2004 | 3 | 36 |
| 2005 | 7 | 67 |
| 2006 | 7 | 58 |
| 2007 | 16 | 63 |
| 2008 | 17 | 59 |
| 2009 | 27 | 77 |
| 2010 | 29 | 91 |
| 2011 | 25 | 92 |
| 2012 | 53 | 97 |
| 2013 | 47 | 109 |
| 2014 | 71 | 113 |
| 2015 | 77 | 124 |
| 2016 | 78 | 154 |
| 2017 | 91 | 135 |
| 2018 | 86 | 135 |
| 2019 | 111 | 162 |
| 2020 | 82 | 162 |
| 2021 | 87 | 138 |
| 2022 | 53 | 149 |
| 2023 | 70 | 142 |
| 2024 | 89 | 139 |
| 2025 | 82 | 119 |
| 2026 | 56 | 94 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Generation of uniform hepatocytes from human embryonic stem cells by inhibiting TGF-beta and methods of maintaining hepatic cultures15 Sep 2026US 12,734,197 B2Wisconsin Alumni Research Foundation
- Generating aorta-gonad-mesonephros-like hematopoietic cells from human pluripotent stem cells under a defined condition15 Sep 2026US 12,735,679 B2Purdue Research Foundation
- Radial glia and astrocyte differentiation from human pluripotent stem cells8 Sep 2026US 12,729,367 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Micropattern-assisted generation of tissue8 Oct 2026US 2026/0308533 A1
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Efficient, scalable production of human retinal progenitors in vitro1 Oct 2026US 2026/0297514 A1
- Rna preparations comprising purified modified rna for reprogramming cells1 Oct 2026US 2026/0297538 A1The Trustees of the University of Pennsylvania
- Radial Glia and Astrocyte Differentiation from Human Pluripotent Stem Cells24 Sep 2026US 2026/0286296 A1The United States of America, as represented by the Secretary, Dept. of Heath and Human Services
Most cited
By later US patents
- Primate embryonic stem cells641US 5,843,780 AWisconsin Alumni Research Foundation · 1998
- Primate embryonic stem cells497US 6,200,806 B1Wisconsin Alumni Research Foundation · 2001
- Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals223US 5,753,506 ACNS Stem Cell Technology, Inc. · 1998
- Definitive endoderm221US 7,510,876 B2Cythera, Inc. · 2009
- Hepatocyte lineage cells derived from pluripotent stem cells175US 6,458,589 B1Geron Corporation · 2002